What is the prevalence of de novo anxiety in adult patients after anterior temporal lobectomy for medically intractable seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

De Novo Anxiety After Temporal Lobectomy

De novo anxiety develops in approximately 20-28% of patients following anterior temporal lobectomy for intractable seizures, making it one of the most common psychiatric complications of this surgery.

Prevalence Data

The most recent and comprehensive evidence indicates that psychiatric disorders are the most frequent postoperative complication after anterior temporal lobectomy, with an estimated frequency of 7% (95% CI: 4-10%) 1. More specifically:

  • 20% of patients develop new psychiatric disorders within 3 months post-surgery 2
  • 28% experience anxiety disorders at 3-month follow-up 2
  • 33% develop anxiety, low mood, or emotional lability in the early postoperative period 3

Important Clinical Context

While these de novo rates appear concerning, the overall picture is more nuanced:

  • Overall anxiety prevalence at 3 months post-surgery is approximately 28%, but this includes both pre-existing and new-onset cases 2
  • The majority of patients (approximately 60%) will have some psychiatric disorder at 3 months, but many had pre-existing conditions 2
  • Recent meta-analytic data shows that anxiety actually decreases significantly after surgery when measured with validated scales like the Hamilton Anxiety Rating Scale (pooled change: -0.87, P < 0.001) 4

Risk Factors for De Novo Anxiety

Younger age is the strongest predictor, with affected patients averaging 27.9 years versus 34.8 years in unaffected patients (P = 0.01) 3. Additional risk factors include:

  • Pre-existing anxiety symptoms on presurgical screening (Hospital Anxiety and Depression Scale score of 12 vs 8.44, P = 0.02) 3
  • Right-sided temporal lobectomy (P = 0.02) 3
  • High preoperative seizure frequency (P < 0.038) 2
  • Seizure recurrence after surgery (P < 0.055) 2

Clinical Implications

The de novo psychiatric symptoms are typically mild in nature and do not adversely affect quality of life in most patients 2. However, they can cause significant clinical problems when they arise, particularly in the 20% who develop entirely new disorders 2.

No clinical characteristic can reliably predict which specific patients will develop de novo psychiatric disorders after surgery 2, though the risk factors above should heighten clinical vigilance.

Practical Management Approach

  • Screen all patients preoperatively for psychiatric disorders, particularly anxiety
  • Counsel younger patients and those with right temporal lesions about increased risk
  • Follow patients with pre-existing anxiety more closely in the postoperative period
  • Conduct systematic psychiatric evaluations at 3 months post-surgery, as this is when most de novo cases manifest 3, 2
  • Consider prophylactic psychiatric follow-up for high-risk patients rather than waiting for symptoms to emerge

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.